Korean Translation of the GRADE Series Published in the BMJ, ‘GRADE: Incorporating Considerations of Resources Use into Grading Recommendations’ (A Secondary Publication)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This article is the fifth translation of a GRADE series published in the BMJ for incorporating the considerations of resources use into grading recommendations. Clinical recommendations inevitably involve judgments about the allocation of resources use (costs). Although costs differ from typical healthcare outcomes, such as mortality, morbidity, and quality of life, costs are another potentially important outcome that differs across and within a jurisdiction. A balance sheet is a useful method for determining if the net benefits are worth the incremental costs. Resource use, not just monetary values, should always be presented in an evidence profile. Formal economic modeling may or may not help judge the certainty of the evidence for resource use.
Abstract
This article is the fifth translation of a GRADE series published in the BMJ for incorporating the considerations of resources use into grading recommendations. Clinical recommendations inevitably involve judgments about the allocation of resources use (costs). Although costs differ from typical healthcare outcomes, such as mortality, morbidity, and quality of life, costs are another potentially important outcome that differs across and within a jurisdiction. A balance sheet is a useful method for determining if the net benefits are worth the incremental costs. Resource use, not just monetary values, should always be presented in an evidence profile. Formal economic modeling may or may not help judge the certainty of the evidence for resource use.
참고문헌 (12)
- Guyatt G, "Addressing resource allocation issues in recommendations from clinical practice guideline panels : suggestions from an American College of Chest Physicians task force", Chest, 129, pp.182~187 (2006)
- Eddy DM, "Comparing benefits and harms : the balance sheet", JAMA, 263, pp.2493~ (1990)
- Altman D, "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial : a randomised placebo-controlled trial", Lancet, 359, pp.1877~1890 (2002)
- Simon J, "Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie trial", BJOG, 113, pp.144~151 (2006)
- Guyatt GH, "Incorporating considerations of resources use into grading recommendations", BMJ, 336, pp.1170~1173 (2008)
- Montori VM, "Users' guide to detecting misleading claims in clinical research reports", BMJ, 329, pp.1093~1096 (2004)
- Luce BR, "Cost-effectiveness in health and medicine", pp.176~213 (1996), Oxford University Press
- Friedberg M, "Evaluation of conflict of interest in economic analyses of new drugs used in oncology", JAMA, 282, pp.1453~1457 (1999)
- Garber AM, "Economic foundations of cost effective analysis", J Health Econ, 16, pp.1~31 (1997)
- Owens DK, "Interpretation of cost-effectiveness analyses", J Gen Intern Med, 13, pp.716~717 (1998)
- Gold MR, "Costeffectiveness in health and medicine" (1996), Oxford University Press
- O’Brien B, "Users' guides to the medical literature: essentials of evidence-based clinical practice", pp.621~644 (2002), AMA Press